S100A9 and Alzheimer disease: IL-12/23 p40 has therefore been shown to be of pathophysiological importance in animal studies of AD and it could be speculated that IL-12/23 p40, like Aβ1–42 and S100A9, could be low in CSF due to increased aggregation/sequestration of IL-12/23 p40 around AD plaques.